Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-11-21
2009-06-16
Szperka, Michael (Department: 1644)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C424S139100, C530S387100
Reexamination Certificate
active
07547767
ABSTRACT:
The present invention provides novel proteins and peptides from the receptor binding region of human Growth Arrest Specific Gene 6 (Gas6) and antibodies, including specified portions or variants, specific for at least one such Gas6 peptide or fragment thereof. The aforesaid peptides can be used to generate human, primate, rodent, mammalian, chimeric, humanized and/or CDR-grafted anti-Gas6 antibodies. The invention also provides for the nucleic acids encoding such peptides and anti-Gas6 antibodies, complementary nucleic acids, vectors, host cells, and methods of making and using thereof, including therapeutic formulations, administration and devices. Fifteen novel peptide sequences from the Gas6 G domain that are implicated in Gas6 interactions with its receptors are identified, isolated, and synthesized so as to allow generation of anti-Gas6 antibodies. The peptide sequences include three ESTs that encompass regions predicted to contribute to receptor binding or that can raise anti-Gas6 antibodies. This invention provides for such antibodies to be used in modulating or treating at least one Gas6-related disease in a cell, tissue, organ, animal, or patient. Such diseases may include, but are not limited to, thromboembolic disease, ischemic disease, venous thromboembolism, arterial or venous thrombosis, pulmonary embolism, restenosis, diabetic angiopathy and allograft atherosclerosis.
REFERENCES:
patent: 5538861 (1996-07-01), Schneider et al.
patent: 5585269 (1996-12-01), Earp, III et al.
patent: 5955420 (1999-09-01), Chen et al.
patent: 6033660 (2000-03-01), Mather et al.
patent: 6169070 (2001-01-01), Chen et al.
patent: 6211142 (2001-04-01), Hammonds et al.
patent: 6455304 (2002-09-01), Weigel et al.
patent: WO 99/49894 (1999-10-01), None
patent: WO 00/53754 (2000-09-01), None
Kuby, Immunology, 2nd Ed, 1994, p. 109-112.
Campbell, Monoclonal Antibody Technology, 1984, p. 1-31.
Manfiolette et al, “The Protein Encoded by a Growth Arrest-Specific Gene (gas6) is a New Member of the Vitamin K-Dependent Proteins related to Protein S, A Negative Coregulator in the Blood Coagulation Cascade,” Molecular and Cellular Biology, 1993, pp. 4976-4985, vol. 13.
Nakano et al, “Requirement of y-carbonxyglutamic acid residues for the biological activity of Gas6: contribution of endogeneous Gas6 to the proliferation of vascular smooth muscle cells,” J. Biochem, 1997, pp. 387-392, vol. 323, Great Britain.
Nagata et al, “Identification of the Product of Growth Arrest-specific Gene 6 as a Common Ligand for Ax1 Sky, and Mer Receptor Tyrosine Kinases,” Journal of Biological Chemistry, 1996, pp. 30022-30027, vol. 271, No. 47, USA.
Mark et al, “Characterization of Gas6, a Member of the Superfamily of G. Domain-containing Proteins, as a Ligand for Rse and Ax1,” Journal of Biological Chemistry, 1996, pp. 9785-9789, vol. 271, No. 16, USA.
Giles-Komar Jill
Heavner George
Jordan Robert
Sweet Ray
Yang Jing
Centocor Ortho Biotech Inc.
Dow Kenneth J.
Kim Yunsoo
Szperka Michael
LandOfFree
Growth arrest specific gene 6 peptides, antibodies,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth arrest specific gene 6 peptides, antibodies,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth arrest specific gene 6 peptides, antibodies,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4145611